News

“Allan has played an instrumental role in the development of our noninvasive prenatal diagnostic division, including serving as the principal investigator in a screening study to clinically assess

Jubilant has said that the software to be launched in the US and Europe initially, allows scientists to capture, store, and analyze Oracle 9i/10g based screening data with

The purpose of the trial is to validate the safety and efficacy of Neurologix’s gene transfer therapy, a novel non-dopaminergic approach to restore motor function in Parkinson’s patients

CD-NP is a novel chimeric natriuretic peptide in clinical development for the treatment of acute heart failure. CD-NP was designed to preserve the favorable effects of current therapies

Tasigna is approved in Japan for the treatment of certain forms of Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia, a rare and potentially fatal cancer of the white blood

According to the company, the Obagi Rosaclear System is the first and only complete prescription-based system developed specifically for treating the signs and symptoms of rosacea. The all-in-one

The small proof-of-concept diabetic vitrectomy (DV) trial has been enrolling slowly due to newer surgical procedures that have resulted in a decreasing number of vitrectomy procedures in the

The special protocol assessment (SPA) provides an agreement between the FDA and Seattle Genetics regarding the design, including size and clinical endpoints, of the pivotal trial to support

Under the terms of the agreement, Sysmex and Epigenomics will assess the suitability of Sysmex’s molecular diagnostics instrumentation for the detection of DNA methylation cancer biomarkers in blood.